Safety and efficacy of concomitant chemotherapeutic wafers and iodine-125 seeds for recurrent glioblastoma

BACKGROUND: Patients with recurrent malignant gliomas have a uniformly poor prognosis. However, further treatment is often warranted at the time of recurrence. Low-activity implanted brachytherapeutic devices, such as iodine-125 seeds, and implantable chemotherapeutic devices such as 1, 3-bis (2-chl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Andrew L., Fink, Kathleen R., Stelzer, Keith M., Silbergeld, Daniel L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515939/
https://www.ncbi.nlm.nih.gov/pubmed/23230518
http://dx.doi.org/10.4103/2152-7806.103644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515939/
https://www.ncbi.nlm.nih.gov/pubmed/23230518
http://dx.doi.org/10.4103/2152-7806.103644

Ejemplares similares